Influence of Continuous Ambulatory Peritoneal Dialysis on Serum Alpha 1-acid Glycoprotein Concentration and Drug Binding

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1988 Jan 1

PMID 3197741

Authors

F M Belpaire

E J van de Velde

N H Fraeyman

M G Bogaert

N Lameire

Affiliations

Soon will be listed here.

Abstract

The influence of continuous ambulatory peritoneal dialysis (CAPD) on the concentrations of alpha 1-acid glycoprotein in serum and dialysate and on the serum binding of oxprenolol, propranolol and phenytoin has been studied. Before starting CAPD treatment, the serum binding of oxprenolol and propranolol was higher and that of phenytoin lower than in healthy volunteers, and the serum alpha 1-AGP concentration was higher. During the first days to weeks after starting CAPD, the serum alpha 1-AGP concentration rose with a concomitant increase in the binding of oxprenolol and propranolol. Subsequently, the alpha 1-AGP level and the binding of oxprenolol and propranolol decreased to the values found before starting CAPD. The binding of phenytoin showed little change. The concentration of alpha 1-AGP in dialysate was 2 to 5% of that in serum.

References

Docci D, Bilancioni R, Pistocchi E, Mosconi G, Turci F, Salvi G . Serum alpha-1-acid glycoprotein in chronic renal failure. Nephron. 1985; 39(3):160-3. DOI: 10.1159/000183364. View

Reidenberg M, Odar-Cederlof I, von Bahr C, Borga O, Sjoqvist F . Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. N Engl J Med. 1971; 285(5):264-7. DOI: 10.1056/NEJM197107292850506. View

Feely J, Forrest A, Gunn A, Hamilton W, Stevenson I, Crooks J . Influence of surgery on plasma propranolol levels and protein binding. Clin Pharmacol Ther. 1980; 28(6):759-64. DOI: 10.1038/clpt.1980.232. View

Fraeyman N, van de Velde E, De Smet F . A monoclonal antibody-based enzyme-linked immunosorbent assay of alpha 1-acid glycoprotein. Clin Chem. 1987; 33(12):2275-7. View

Lin T, Sugiyama Y, Sawada Y, Suzuki Y, Iga T, Hanano M . Effect of surgery on serum alpha 1-acid glycoprotein concentration and serum protein binding of DL-propranolol in phenobarbital-treated and untreated rats. Drug Metab Dispos. 1987; 15(1):138-40. View

Fremstad D, Bergerud K, Haffner J, Lunde P . Increased plasma binding of quinidine after surgery: a preliminary report. Eur J Clin Pharmacol. 1976; 10(6):441-4. DOI: 10.1007/BF00563081. View

Pedersen L, Bonde J, Graudal N, Backer N, Hansen J, Kampmann J . Quantitative and qualitative binding characteristics of disopyramide in serum from patients with decreased renal and hepatic function. Br J Clin Pharmacol. 1987; 23(1):41-6. PMC: 1386138. DOI: 10.1111/j.1365-2125.1987.tb03007.x. View

Wilkinson G, SHAND D . Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther. 1975; 18(4):377-90. DOI: 10.1002/cpt1975184377. View

Henriksen H, Petersen M, Pedersen F . Serum alpha-1-acid glycoprotein (orosomucoid) in uremic patients on hemodialysis. Nephron. 1982; 31(1):24-6. DOI: 10.1159/000182605. View

10.

Haughey D, Kraft C, Matzke G, Keane W, Halstenson C . Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipients. Am J Nephrol. 1985; 5(1):35-9. DOI: 10.1159/000166900. View

11.

Doumas B, Watson W, BIGGS H . Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta. 1971; 31(1):87-96. DOI: 10.1016/0009-8981(71)90365-2. View

12.

Yasuhara M, Fujiwara J, Kitade S, Katayama H, Okumura K, Hori R . Effect of altered plasma protein binding on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery: role of alpha-1-acid glycoprotein. J Pharmacol Exp Ther. 1985; 235(2):513-20. View

13.

Piafsky K, Borga O, Odar-Cederlof I, Johansson C, Sjoqvist F . Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. N Engl J Med. 1978; 299(26):1435-9. DOI: 10.1056/NEJM197812282992604. View

14.

Grossman S, Davis D, Kitchell B, SHAND D, Routledge P . Diazepam and lidocaine plasma protein binding in renal disease. Clin Pharmacol Ther. 1982; 31(3):350-7. DOI: 10.1038/clpt.1982.45. View

15.

Belpaire F, Bogaert M, Rosseneu M . Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum. Eur J Clin Pharmacol. 1982; 22(3):253-6. DOI: 10.1007/BF00545224. View